A2A Pharmaceuticals, Inc. - SEC Form 4 Insider Trading Screener

General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
6 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

M
2023-05-31
BMEAA2A Pharmaceuticals, Inc.10%S - Sale$34.11-125,0003,500,000-3%-$4,263,915
2023-05-12
BMEAA2A Pharmaceuticals, Inc.10%S - Sale$33.84-25,0003,625,000-1%-$846,000
M
2023-05-08
BMEAA2A Pharmaceuticals, Inc.10%S - Sale$34.30-250,0003,650,000-6%-$8,575,030
2023-04-20
BMEAA2A Pharmaceuticals, Inc.10%S - Sale$29.12-200,0003,900,000-5%-$5,823,760
A
2023-03-31
BMEAA2A Pharmaceuticals, Inc.10%S - Sale$31.25-200,0004,100,000-5%-$6,250,000
2023-03-31
BMEAA2A Pharmaceuticals, Inc.10%S - Sale$31.25-200,0004,100,000-5%-$6,250,000

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top